| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6158275 | American Journal of Kidney Diseases | 2010 | 18 Pages |
Abstract
Measures of kidney function are used commonly as surrogate end points in kidney transplant trials, with eGFR becoming more frequently used over time. Further data are needed to properly validate these surrogate end points and fully understand their limitations when designing and interpreting randomized trials.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Christine A. MD, MSc, Deborah MD, MSc, Ayub MD, MSc, Greg A. MD, MSc,